Management cease trade order
MYDECINE RECEIVES MANAGEMENT CEASE TRADE ORDER VANCOUVER, British Columbia, 3 May 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) announces that it has received a temporary Management Cease Trade Order (“MCTO”) on April 26, 2024, under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”) from the British Columbia Securities Commission (“BCSC”) in connection with the Company’s filing of its audited annual financial statements and MD&A for the financial year ended December 31, 2023. Pursuant to the MCTO, the chief